Tom 7, Nr 6 (2021)
Artykuł przeglądowy
Opublikowany online: 2021-12-20
Wyświetlenia strony
3694
Wyświetlenia/pobrania artykułu
482
Przyczyny BIA-ALCL — podsumowanie aktualnego stanu wiedzy
1
, 1, 2, 3, 14
, 1, 2, 3, 14
Onkol Prakt Klin Edu 2021;7(6):402-408.
Streszczenie
Przyczyny rozwoju anaplastycznego chłoniaka wielkokomórkowego związanego z implantami piersi (BIA-ALCL) są ostatnio dość popularnym tematem, budzącym szczególne zainteresowanie chirurgów plastycznych, chirurgów onkologicznych, hematologów i onkologów. W ciągu ostatniej dekady ukazało się wiele publikacji na ten temat. Potencjalne czynniki etiopatogenetyczne obejmują rodzaj implantów, biofilm, obecność stanu zapalnego, mikrourazy i mutacje genetyczne. W stosunku do żadnej z tych potencjalnych przyczyn nie uzyskano jednak dotychczas wystarczających dowodów naukowych, w każdym razie nie należy ich rozpatrywać osobno, ponieważ prawdopodobnie występują one jednocześnie. Określenie głównego czynnika etiopatogenetycznego wymaga dalszych badań i wymiany doświadczeń między klinicystami i badaczami. Przyczyniłoby się to do poszerzenia możliwości zastosowania skutecznej profilaktyki u pacjentek poddawanych operacji wszczepienia implantów piersi, a być może nawet wyeliminowania BIA-ALCL.
Słowa kluczowe: czynniki etiologiczne BIA-ALCLimplanty piersianaplastyczny chłoniak wielkokomórkowy związany z implantami piersipowikłania chirurgii onkologicznej i plastycznej
Referencje
- Hedén P, Stark B. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)]. Lakartidningen. 2018; 115.
- Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, et al. Pioneers of Breast Implant-Associated Anaplastic Large Cell Lymphoma: History from Case Report to Global Recognition. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 7S–714S.
- BIA-ALCL Physician Resources [Internet]. American Society of Plastic Surgeons. https://www.plasticsurgery.org/for-medical-professionals/health-policy/bia-alcl-physician-resources (24.04.2020).
- Rastogi P, Deva AK, Prince HM. Breast Implant-Associated Anaplastic Large Cell Lymphoma. Curr Hematol Malig Rep. 2018; 13(6): 516–524.
- Collett DJ, Rakhorst H, Lennox P, et al. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants. Plast Reconstr Surg. 2019; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma): 30S–40S.
- Calobrace MB, Schwartz MR, Zeidler KR, et al. Long-Term Safety of Textured and Smooth Breast Implants. Aesthet Surg J. 2017; 38(1): 38–48.
- Allergan Recalls Natrelle Biocell Textured Breast Implants Due to Risk of BIA-ALCL Cancer [Internet]. US FOOD&DRUG ADMINISTRATION. https://www.fda.gov/medical-devices/medical-device-recalls/allergan-recalls-natrelle-biocell-textured-breast-implants-due-risk-bia-alcl-cancer (24.04.2020).
- General and Plastic Surgery Devices Panel March 25-26, 2019 Mentor Briefing Package[Internet]. US FOOD&DRUG ADMINISTRATION. https://www.fda.gov/media/123013/ (24.04.2020).
- Peters W, Young V, Jerina K. Biomaterials in Plastic Surgery: Breast Implants. Woodhead Publishing 2012: 98.
- Hamdi M. Association Between Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Risk and Polyurethane Breast Implants: Clinical Evidence and European Perspective. Aesthet Surg J. 2019; 39(Suppl_1): S49–S54.
- Magnusson M, Beath K, Cooter R, et al. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Plast Reconstr Surg. 2019; 143(5): 1285–1292.
- Blombery P, Thompson ER, Jones K, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016; 101(9): e387–e390.
- O'Shea JJ, Schwartz DM, Villarino AV, et al. The JAK-STAT pathway: impact on human disease and therapeutic intervention. Annu Rev Med. 2015; 66: 311–328.
- Thomas SJ, Snowden JA, Zeidler MP, et al. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br J Cancer. 2015; 113(3): 365–371.
- Oishi N, Miranda RN, Feldman AL. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019; 39(Suppl_1): S14–S20.
- Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987; 237(4822): 1588–1595.
- Chagnot C, Zorgani MA, Astruc T, et al. Proteinaceous determinants of surface colonization in bacteria: bacterial adhesion and biofilm formation from a protein secretion perspective. Front Microbiol. 2013; 4: 303.
- Habimana O, Semião A, Casey E. The role of cell-surface interactions in bacterial initial adhesion and consequent biofilm formation on nanofiltration/reverse osmosis membranes. Journal of Membrane Science. 2014; 454: 82–96.
- Rochford ETJ, Richards RG, Moriarty TF. Influence of material on the development of device-associated infections. Clin Microbiol Infect. 2012; 18(12): 1162–1167.
- Tieszer C, Reid G, Denstedt J. Conditioning film deposition on ureteral stents after implantation. J Urol. 1998; 160(3 Pt 1): 876–881.
- Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005; 28(11): 1062–1068.
- Jacombs A, Tahir S, Hu H, et al. In vitro and in vivo investigation of the influence of implant surface on the formation of bacterial biofilm in mammary implants. Plast Reconstr Surg. 2014; 133(4): 471e–480e.
- Hu H, Jacombs A, Vickery K, et al. Chronic biofilm infection in breast implants is associated with an increased T-cell lymphocytic infiltrate: implications for breast implant-associated lymphoma. Plast Reconstr Surg. 2015; 135(2): 319–329.
- Hu H, Johani K, Almatroudi A, et al. Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016; 137(6): 1659–1669.
- Clemens MW, DeCoster RC, Fairchild B, et al. Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Semin Plast Surg. 2019; 33(4): 270–278.
- Sorotos M, Longo B, Amorosi V, et al. Macrotextured Breast Implants with Defined Steps to Minimize Bacterial Contamination around the Device: Experience in 42,000 Implants. Plast Reconstr Surg. 2018; 142(3): 412e–413e.
- Ryan MP, Adley CC. The antibiotic susceptibility of water-based bacteria Ralstonia pickettii and Ralstonia insidiosa. J Med Microbiol. 2013; 62(Pt 7): 1025–1031.
- Wee AT, Morrey BF, Sanchez-Sotelo J. The fate of elbows with unexpected positive intraoperative cultures during revision elbow arthroplasty. J Bone Joint Surg Am. 2013; 95(2): 109–116.
- Ryan MP, Adley CC. Ralstonia spp.: emerging global opportunistic pathogens. Eur J Clin Microbiol Infect Dis. 2014; 33(3): 291–304.
- Coussens L, Werb Z. Inflammation and cancer. Nature. 2002; 420(6917): 860–867.
- Stefanko E, Wróbel T. Etiopatogeneza infekcyjna chłoniaków. Hematol. 2010(1): 288–295.
- Kadin ME, Deva A, Xu H, et al. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016; 36(7): 773–781.
- Bizjak M, Selmi C, Praprotnik S, et al. Silicone implants and lymphoma: The role of inflammation. J Autoimmun. 2015; 65: 64–73.
- Handel N, Gutierrez J. Long-term safety and efficacy of polyurethane foam-covered breast implants. Aesthet Surg J. 2006; 26(3): 265–274.
- Brody GS. The Case against Biofilm as the Primary Initiator of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2016; 137(4): 766e–767e.
- Clemens MW, Nava MB, Rocco N, et al. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017; 6(2): 169–184.
- Kaartinen I, Sunela K, Alanko J, et al. Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment. Eur J Surg Oncol. 2017; 43(8): 1385–1392.
- Wise LA, Palmer JR, Boggs DA, et al. Abuse victimization and risk of breast cancer in the Black Women's Health Study [corrected]. Cancer Causes Control. 2011; 22(4): 659–669.
- Rigby JE, Morris JA, Lavelle J, et al. Can physical trauma cause breast cancer? Eur J Cancer Prev. 2002; 11(3): 307–311.
- Kuraishy A, Karin M, Grivennikov SI. Tumor promotion via injury- and death-induced inflammation. Immunity. 2011; 35(4): 467–477.
- Center for Devices and Radiological Health [Internet]. U.S. Food and Drug Administration. Anaplastic large cell lymphoma (ALCL) in women with breast implants: preliminary FDA findings and analysis. http://www.fda.gov/downloads/MedicalDevices/ProductsandMedicalProcedures/Implant- sandProsthetics/BreastImplants/UCM240003 (24.04.2020).
- Pupka D, Sawicki T, Sikora J, et al. Zakażenie miejsca operowanego – postępowanie. Chirurgia po Dyplomie. 2019; 02.
- Cordeiro PG, Ghione P, Ni A, et al. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants. J Plast Reconstr Aesthet Surg. 2020; 73(5): 841–846.
- Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04220970 (24.10.2020).
